IHT Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-03-08
Share capital
5,000.00 PLN
Registered address
ul. Europejska 14D, 02-964 Warszawa, Poland
Phone

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 57 days early.

  • 202508/05/2026
  • 202420/05/2025
  • 202310/05/2024
  • 202206/07/2023
  • 202121/06/2022
  • 202021/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 566.31kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 46.61kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 513.32kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 175.16kMedianUSD 608.93kAverageUSD 11.85m

Public procurement

129 tenders recorded as contractor: 41 national ($732,909) and 88 EU ($3,045,090).

SubjectAmount
Zakup i dostawa materiałów opatrunkowych i obłożeń operacyjnych wraz z dzierżawą urządzeń (dot. części 34 i 35) na bieżące potrzeby Uniwersyteckiego Szpitala Klinicznego w Opolu.
$19,769
Supply of wound dressings for cozl.
$19,982
171/PN/2026 – Supply of disposable medical devices for uck
$1,838

Authorized Representatives

Anna Lępkowska Maciążek – President of the Management Board
Julia Prusaczyk – Management Board Member

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

OwnerSharesShare valueStake
Iberhospitex S.A.
60$810.3760%
Anna Małgorzata Lępkowska Maciążekage 63
35$472.7235%
Others
5$67.535%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-05-11.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $19,618.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,606
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,606

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Dental Solutionssp. z o.o.
Beauty Care Solutionsp. z o.o.
Aimedicalsp. z o.o.
Vorwarts Pharmasp. z o.o.
Black & Whitesp. z o.o.
Osteoprofsp. z o.o.
THC PharmaS.A.
EDGE Pharmasp. z o.o.
Arcade Internationalsp. z o.o.
Filicosp. z o.o.

FAQ

Last updated: 2026-05-08